Walmart Settles Opioid Prescription Allegations with $50 Million Payment to Justice Department
Walmart Inc. has reached a $50 million settlement with the U.S. Justice Department and the Drug Enforcement Administration (DEA) to resolve allegations that its pharmacies illegally filled thousands of invalid opioid and other controlled substance prescriptions. The government's complaint, filed in December 2020 and amended in 2022, alleged that since June 26, 2013, Walmart's compliance team and pharmacists knowingly dispensed invalid prescriptions. According to the Justice Department, Walmart's compliance team was aware that certain prescribers were operating as 'pill mills' but continued to fill prescriptions from them. Pharmacists reportedly identified red flags such as dangerous drug combinations, excessively repeated high-dosage fills, or frequent early refill requests for often-abused controlled substances, yet these prescriptions were still dispensed. The settlement includes a memorandum of agreement with the DEA, requiring Walmart to implement measures to prevent future violations.